CD14 C-159T polymorphism and its association with chronic lung diseases: A pilot study on isocyanate exposed population of Central India.
dc.contributor.author | Bose, Protiti | |
dc.contributor.author | Bathri, Rashmi | |
dc.contributor.author | De, Sajal | |
dc.contributor.author | Maudar, K K | |
dc.date.accessioned | 2013-11-20T08:41:51Z | |
dc.date.available | 2013-11-20T08:41:51Z | |
dc.date.issued | 2013-04 | |
dc.description.abstract | CONTEXT: CD14 functions as a multifunctional receptor for bacterial cell wall components including endotoxin and lipopolysaccharide and is likely to influence the cytokine profile and subsequent immunoglobulin E production in response to antigen/allergen contact in allergic phenotypes. AIMS: The present study was to investigate genetic polymorphism in CD14 gene - 159C/T, which may be one of the risk factor for increased prevalence of Chronic Lung Diseases in the Central India. SETTINGS AND DESIGN: Survivors of Methyl isocyanates toxicity in Bhopal still suffering from various respiratory ailments were examined. MATERIALS AND METHODS: Polymerase chain reaction-restriction fragment length polymorphism was performed to determine the polymorphism of C-159T. RESULTS: The genotype and allelic frequencies were in Hardy-Weinberg’s equilibrium. Prevalence of CC, CT, and TT were 5.5%, 22.2% and 9.25% respectively in asthmatics; 16.6%, 20.3% and 5.5% respectively in chronic obstructive pulmonary disease (COPD) patients and 5.5%, 14.8% and 1.85 respectively among interstitial lung disorder (ILD) patients; whereas the control cohort with no methyl isocyanate exposure displayed (CC, CT, and TT) cytosine, thymine as 2%, 1.6% and 2% respectively. Increased risk of Asthma among those carrying TT genotype and T allele (odds ratio [OR] =2.61 and 2.02 respectively). CONCLUSION: COPD risk significantly found among those with CC genotype and C allele (OR = 2.81 and 1.50 respectively), whereas ILD risk found significantly among CT genotype and C allele (OR = 1.75 and 1.40 respectively). Therefore, single nucleotide polymorphism (SNP) C-159T polymorphism in CD14 gene might be a risk factor for development of CLD in this population. | en_US |
dc.identifier.citation | Bose Protiti, Bathri Rashmi, De Sajal, Maudar K K. CD14 C-159T polymorphism and its association with chronic lung diseases: A pilot study on isocyanate exposed population of Central India. Indian Journal of Human Genetics. 2013 Apr; 19(2): 188-195. | en_US |
dc.identifier.uri | https://imsear.searo.who.int/handle/123456789/149428 | |
dc.language.iso | en | en_US |
dc.source.uri | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3758726/?report=classic | en_US |
dc.subject | Asthma | en_US |
dc.subject | Bhopal | en_US |
dc.subject | CD14 | en_US |
dc.subject | chronic obstructive methyl isocyanate | en_US |
dc.subject | pulmonary disease | en_US |
dc.subject.mesh | Aged | |
dc.subject.mesh | Antigens, CD14 --genetics | |
dc.subject.mesh | Asthma --epidemiology | |
dc.subject.mesh | Bhopal Accidental Release | |
dc.subject.mesh | Chronic Disease | |
dc.subject.mesh | Female | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Isocyanates --adverse effects | |
dc.subject.mesh | Lung Diseases --chemically induced | |
dc.subject.mesh | Lung Diseases --epidemiology | |
dc.subject.mesh | Lung Diseases --etiology | |
dc.subject.mesh | Lung Diseases --genetics | |
dc.subject.mesh | Male | |
dc.subject.mesh | Middle Aged | |
dc.subject.mesh | Polymorphism, Genetic | |
dc.subject.mesh | Population Groups --epidemiology | |
dc.subject.mesh | Population Groups --genetics | |
dc.title | CD14 C-159T polymorphism and its association with chronic lung diseases: A pilot study on isocyanate exposed population of Central India. | en_US |
dc.type | Article | en_US |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- ijhg2013v19n2p188.pdf
- Size:
- 469.74 KB
- Format:
- Adobe Portable Document Format
- Description:
- Journal article
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: